Please use this identifier to cite or link to this item:
|Title:||In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment||Authors:||Natu, Mădălina V.
Gaspar, Manuel N.
Ribeiro, Carlos A. Fontes
Cabrita, António M.
Sousa, Hermínio C. de
Gil, M. H.
|Keywords:||Poly(ɛ-caprolactone); Subconjunctival implant; Controlled drug release; In vivo; Intraocular pressure; Glaucoma||Issue Date:||Jul-2011||Publisher:||Elsevier||Citation:||NATU, Mădălina V. [et al.] - In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment. "International Journal of Pharmaceutics". ISSN 0378-5173. 415:1–2 (2011) 73-82||Serial title, monograph or event:||International Journal of Pharmaceutics||Volume:||415||Issue:||1-2||Abstract:||Implantable disks for glaucoma treatment were prepared by blending poly(ɛ-caprolactone), PCL, poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) and dorzolamide. Their in vivo performance was assessed by their capacity to decrease intraocular pressure (IOP) in normotensive and hypertensive eyes. Drug mapping showed that release was complete from blend disks and the low molecular weight (MW) PCL after 1 month in vivo. The high MW PCL showed non-cumulative release rates above the therapeutic level during 3 months in vitro. In vivo, the fibrous capsule formation around the implant controls the drug release, working as a barrier membrane. Histologic analysis showed normal foreign body reaction response to the implants. In normotensive eyes, a 20% decrease in IOP obtained with the disks during 1 month was similar to Trusopt® eyedrops treatment. In hypertensive eyes, the most sustained decrease was shown by the high MW PCL (40% after 1 month, 30% after 2 months). It was shown that the implants can lower IOP in sustained manner in a rabbit glaucoma model.||URI:||http://hdl.handle.net/10316/21650||ISSN:||0378-5173||DOI:||10.1016/j.ijpharm.2011.05.047||Rights:||openAccess|
|Appears in Collections:||FCTUC Eng.Química - Artigos em Revistas Internacionais|
Show full item record
Files in This Item:
|In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment.pdf||1.32 MB||Adobe PDF||View/Open|
checked on Feb 18, 2020
WEB OF SCIENCETM
checked on Aug 2, 2022
checked on Aug 4, 2022
checked on Aug 4, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.